ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 70

Colocalization of Malondialdehyde-Acetaldehyde Adducts (MAA) and Extracellular Matrix Proteins in Joint and Lung Tissues from Rheumatoid Arthritis Patients

Geoffrey M. Thiele1, Michael J. Duryee2, Jacob D. McGowan1, Logan M. Duryee1, Lynell W. Klassen3, James R. O'Dell3, Bryant R. England4 and Ted R. Mikuls5, 1University of Nebraska Medical Center, Omaha, NE, 2Internal Medicine Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE, 3Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, 4Rheumatology, VA Nebraska-Western Iowa Health Care System & University of Nebraska Medical Center, Omaha, NE, 5Internal Medicine, Division of Rheumatology, VA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: citrullination, extracellular matrix proteins, Lung Disease, pathogenesis and rheumatoid arthritis, rheumatoid arthritis, synovium

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Rheumatoid Arthritis – Etiology and Pathogenesis Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:   Malondialdehyde-acetaldehyde adducts (MAA) are products of oxidative stress that modify self-proteins and stimulate potent cellular and humoral immune responses. We have previously demonstrated that MAA adducts are present in lung and joint tissues from rheumatoid arthritis (RA) patients and colocalize with citrullinated proteins. Moreover, anti-MAA antibodies are associated with higher RA disease activity and extra articular features including interstitial lung disease (ILD).  However, the adducted protein(s) driving these immune responses are unknown. Implicated as pathogenic target autoantigens; we characterized extracellular matrix (ECM) protein and MAA expression in RA lung and joint tissues.

Methods:   Paraffin embedded joint tissues from osteoarthritis (OA) and RA patients (n=5 each) were stained for MAA, vimentin, fibronectin, and collagen II. Similarly, we stained non-paired lung tissues from subjects with RA-ILD and controls (n=3 each).  Tissues were assessed with confocal microscopy and staining patterns were quantified using Zen and image J software.  Co-localization of ECM proteins with MAA was determined using the Fiji plugin, Coloc 2. Pearson’s correlation coefficients were calculated and compared between disease groups for lung and synovium. 

Results:   MAA, vimentin, and fibronectin expression (but not collagen II) were all significantly higher in joint tissues from RA compared to OA patients (*P<0.001) Fig 1A. Colocalization of MAA with vimentin was significantly greater than that observed with other ECM proteins in RA synovium (*P<0.001) Fig 1B/C.  In lung tissues, all 3 ECM proteins and MAA were all significantly increased in RA-ILD vs. normal controls (#P<0.03) Fig 1A.  Colocalization of MAA with the ECM proteins (Collagen II and Vimentin) was increased in RA-ILD lung tissue.  Similar to RA joint tissues, colocalization with MAA and vimentin was observed (R=0.77). However, collagen II was significantly increased (#P<0.001) in the lung compared to the joint Fig 1B/C. 

Conclusion:   Enhanced colocalization of critically important ECM proteins with MAA in diseased tissues, in addition to prior observations of increased anti-MAA antibody responses in RA, suggests a mechanistic role of MAA in RA synovial and lung disease. Moreover, these results suggest that interactions between MAA and ECM proteins are tissue dependent with MAA modification of vimentin potentially shared between the lung and synovium, while MAA modification of collagen may be more lung predominant. 


Disclosure: G. M. Thiele, None; M. J. Duryee, None; J. D. McGowan, None; L. M. Duryee, None; L. W. Klassen, None; J. R. O'Dell, Medac, 5; B. R. England, None; T. R. Mikuls, BMS, Ironwood, Horizon, 2,Pfizer, Inc., 5.

To cite this abstract in AMA style:

Thiele GM, Duryee MJ, McGowan JD, Duryee LM, Klassen LW, O'Dell JR, England BR, Mikuls TR. Colocalization of Malondialdehyde-Acetaldehyde Adducts (MAA) and Extracellular Matrix Proteins in Joint and Lung Tissues from Rheumatoid Arthritis Patients [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/colocalization-of-malondialdehyde-acetaldehyde-adducts-maa-and-extracellular-matrix-proteins-in-joint-and-lung-tissues-from-rheumatoid-arthritis-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/colocalization-of-malondialdehyde-acetaldehyde-adducts-maa-and-extracellular-matrix-proteins-in-joint-and-lung-tissues-from-rheumatoid-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology